Insights into new Alzheimer´s treatments
September 18, 2023
This episode features an interview with Ram Mukunda and Claudia Grimaldi from IGC Pharma, a clinical-stage pharmaceutical company
New resource available view now
New resource available view now
This episode features an interview with Ram Mukunda and Claudia Grimaldi from IGC Pharma, a clinical-stage pharmaceutical company
Ram Mukunda and Claudia Grimaldi, representing IGC Pharma, a pharmaceutical company in the clinical stage dedicated to enhancing the health of Alzheimer’s disease patients and making these treatments accessible, appear on eHealth Radio and the Alzheimer’s Information and Health News Channels.
Kenia Andrade, Pharma Marketing Manager at IGC Pharma overseeing HOLIEF, a holistic women’s health brand from IGC Pharma and Dr. Juanita Arbelaez, Medical Researcher at IGC Pharma joins eHealth Radio and the Female Health and Health News Channels.
IGC will aim for FDA fast-track designation after a Phase II trial investigating IGC-AD1 with AD patients concludes in Q1 2024.
Discover cutting-edge dementia science at AAIC Amsterdam. Breakthroughs and connections thrive as leading experts unite at the world’s largest conference on Alzheimer’s research.
Discover the remarkable innovation of IGC Pharma, highlighted in BENZINGA publication.
On May 14, Prof Govindaraju received the Government of India-instituted National Technology Award for outstanding contribution in commercialising innovative indigenous technologies from the Minister of State for Science and Technology and Earth Sciences, Dr Jitendra Singh.
SOURCE https://www.youtube.com/watch?v=gtE3SROFPXg
Hamsa Biopharma, which will take the drug †Christened TGR63†to trials through its parent company in the US, IGC Pharma, hopes it can eventually be made available in the market.
Researchers in India say they have discovered a promising drug target that may slow or even halt the progression of Alzheimer’s.